Ipsen

U.S.-listed shares of Genfit soar 24% after positive results from late-stage trial of treatment for rare type of liver disease

6:44 a.m. June 30, 2023

- Ciara Linnane

Tanking Biotech Stocks Will Mean a Big Year for Deals. Who Could Benefit.

3:00 a.m. Jan. 14, 2023

- Barron's Online

Is pharma M&A making a comeback?

8:22 a.m. Jan. 13, 2023

- Jaimy Lee

European drugmakers including AstraZeneca pony up for U.S.-listed biopharmas

7:58 a.m. Jan. 9, 2023

- Steve Goldstein

Merrimack stock rockets 200% after positive trial data on Onivyde pancreatic cancer treatment

11:13 a.m. Nov. 9, 2022

- Tomi Kilgore

This ‘underappreciated’ black swan could bring fresh chaos to the global economy

9:24 a.m. June 27, 2022

- Barbara Kollmeyer

This group of stocks is flagging a rebound, and that’s good news for the S&P 500, says technical analyst

10:14 a.m. March 22, 2022

- Barbara Kollmeyer

Europe stocks are about to log a 10th straight gain. Here’s why Bank of America is worried.

8:02 a.m. Aug. 13, 2021

- Barbara Kollmeyer

Syndax Pharmaceuticals Gains 57% After Cancer Conference

5:29 p.m. April 28, 2020

- Barron's Online

Stocks close higher as Trump delays China tariff deadline

5:35 p.m. Feb. 25, 2019

- Sue Chang

‘Oblivious’ investors aren’t ready for the bursting of the ‘everything bubble,’ hedge-fund manager warns

1:09 p.m. Feb. 25, 2019

- Shawn Langlois

Ipsen profit up; hemophilia-drug partnership set

2:12 a.m. Aug. 30, 2011

- Robert Daniel

Roche disappoints as revamp costs weigh

3:52 a.m. Feb. 2, 2011

- Goran Mijuk

Updates, advisories and surprises

10:01 p.m. March 1, 2010

- MarketWatch

Ipsen '09 net rose 6.8% on 7.2% higher revenue

2:49 a.m. March 1, 2010

- Robert Daniel

Pharmas help Europe stocks end losing run

12:59 p.m. Jan. 26, 2010

- Sarah Turner

Novo Nordisk rallies as FDA clears diabetes drug

7:44 a.m. Jan. 26, 2010

- Steve Goldstein

European shares edge higher; Vodafone rises

1:13 p.m. Dec. 2, 2009

- Sarah Turner

Roche says new diabetes drug works better than Merck's Januvia

3:59 a.m. Dec. 2, 2009

- MarketWatch.com

Ipsen sees upper-end FY revenue

1:42 a.m. July 31, 2008

- Steve Goldstein

Why Biotech Is Poised for a Recovery This Year

12:43 p.m. May 31, 2023

- The Wall Street Journal Interactive Edition

Big Pharma Won’t Bail Out Battered Biotech

2:34 a.m. July 1, 2022

- The Wall Street Journal Interactive Edition

Roche Diabetes Drug Faces Delay

8:34 a.m. June 18, 2010

- The Wall Street Journal Interactive Edition